176 related articles for article (PubMed ID: 28232262)
1. Prevalence, predictors, and outcomes of advance directives in implantable cardioverter-defibrillator recipients.
Merchant FM; Binney Z; Patel A; Li J; Peddareddy LP; El-Chami MF; Leon AR; Quest T
Heart Rhythm; 2017 Jun; 14(6):830-836. PubMed ID: 28232262
[TBL] [Abstract][Full Text] [Related]
2. The use of advance directives among patients with implantable cardioverter defibrillators.
Tajouri TH; Ottenberg AL; Hayes DL; Mueller PS
Pacing Clin Electrophysiol; 2012 May; 35(5):567-73. PubMed ID: 22432897
[TBL] [Abstract][Full Text] [Related]
3. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
4. Advance directives among hospitalized patients with heart failure.
Butler J; Binney Z; Kalogeropoulos A; Owen M; Clevenger C; Gunter D; Georgiopoulou V; Quest T
JACC Heart Fail; 2015 Feb; 3(2):112-21. PubMed ID: 25543976
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
Koman E; Gupta A; Subzposh F; Saltzman H; Kutalek SP
J Interv Card Electrophysiol; 2016 Mar; 45(2):219-23. PubMed ID: 26768264
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and contents of advance directives in patients with pacemakers.
Pasalic D; Tajouri TH; Ottenberg AL; Mueller PS
Pacing Clin Electrophysiol; 2014 Apr; 37(4):473-80. PubMed ID: 24215172
[TBL] [Abstract][Full Text] [Related]
7. Palliative Care Consultation and Associated End-of-Life Care After Pacemaker or Implantable Cardioverter-Defibrillator Deactivation.
Pasalic D; Gazelka HM; Topazian RJ; Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Mueller PS
Am J Hosp Palliat Care; 2016 Dec; 33(10):966-971. PubMed ID: 26169518
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial.
Gopinathannair R; Lerew DR; Cross NJ; Sears SF; Brown S; Olshansky B
J Interv Card Electrophysiol; 2017 Apr; 48(3):291-298. PubMed ID: 28220279
[TBL] [Abstract][Full Text] [Related]
9. Exploring Advance Directive Perspectives and Associations with Preferences for End-of-Life Life-Sustaining Treatments among Patients with Implantable Cardioverter-Defibrillators.
Kim J; Park HW; An M; Shim JL
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549238
[TBL] [Abstract][Full Text] [Related]
10. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
Thijssen J; van den Akker van Marle ME; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2014 Jan; 37(1):25-34. PubMed ID: 23998638
[TBL] [Abstract][Full Text] [Related]
12. Rates of upgrade of ICD recipients to CRT in clinical practice and the potential impact of the more liberal use of CRT at initial implant.
Scott PA; Whittaker A; Zeb M; Watts E; Yue AM; Roberts PR; Morgan JM
Pacing Clin Electrophysiol; 2012 Jan; 35(1):73-80. PubMed ID: 22054072
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience and procedural outcomes associated with the DF4 implantable cardioverter defibrillator system: the SJ4 postapproval study.
Cantillon DJ; Ha K; Styperek R; Jumrussirikul P; Mirro M; Wong W; Wilkoff BL
Pacing Clin Electrophysiol; 2013 Jul; 36(7):855-62. PubMed ID: 23617316
[TBL] [Abstract][Full Text] [Related]
14. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
[TBL] [Abstract][Full Text] [Related]
15. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
[TBL] [Abstract][Full Text] [Related]
16. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
[TBL] [Abstract][Full Text] [Related]
17. Effect of Significant Weight Change on Inappropriate Implantable Cardioverter-Defibrillator Therapy.
Daimee UA; Biton Y; Aktas MK; Zannad F; Klein H; Szepietowska B; McNitt S; Polonsky B; Wang PJ; Zareba W; Moss AJ; Kutyifa V
Pacing Clin Electrophysiol; 2017 Jan; 40(1):9-16. PubMed ID: 27808410
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.
Thijssen J; Borleffs CJ; van Rees JB; Man S; de Bie MK; Venlet J; van der Velde ET; van Erven L; Schalij MJ
Heart Rhythm; 2012 Apr; 9(4):513-9. PubMed ID: 22094073
[TBL] [Abstract][Full Text] [Related]
19. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
[TBL] [Abstract][Full Text] [Related]
20. Improving Communication in Heart Failure Patient Care.
Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
